Linaclotide-a Novel Secretagogue in the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|13|11|1685-1690

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.13, Iss.11, 2013-10, pp. : 1685-1690

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Linaclotide: a novel compound for the treatment of irritable bowel syndrome with constipation

By Rothstein Robin D Friedenberg Frank K

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 15, 2013-10 ,pp. : 2125-2132

Informa Healthcare

Access to resources Recommend Favorite

Renzapride: a new drug for the treatment of constipation in the irritable bowel syndrome

By Scarpellini Emidio Tack Jan

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 11, 2008-11 ,pp. : 1663-1670

Informa Healthcare

Access to resources Recommend Favorite

Lubiprostone: In Constipation-Predominant Irritable Bowel Syndrome

By Carter Natalie J. Scott Lesley J.

Drugs, Vol. 69, Iss. 9, 2009-06 ,pp. : 1229-1237

Adis International

Access to resources Recommend Favorite

Tegaserod: A Review of its Use in the Management of Irritable Bowel Syndrome with Constipation in Women

By Wagstaff A.J. Frampton J.E. Croom K.F.

Drugs, Vol. 63, Iss. 11, 2003-01 ,pp. : 1101-1120

Adis International

Access to resources Recommend Favorite

Tegaserod: a promising option in women with irritable bowel syndrome with constipation

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 20, Iss. 6, 2004-06 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite